Under the Dubai Industrial Strategy 2030, pharmaceuticals and medical devices have been identified as one of the six key industries for development, highlighting the UAE's ambition to become a global pharmaceutical hub. Planet Pharmacies LLC, a subsidiary of the Julphar Group and one of the largest pharmaceutical suppliers in the Middle East and Africa, will leverage the Taiwan Healthcare+ Expo to seek partnerships in biotechnology, regenerative medicine, and precision diagnostics.

When mentioning Thailand, many people think of the world-renowned Thai massage. However, its physical therapy and rehabilitation technologies are also experiencing rapid growth. Thailand's leading brand in the field of physical therapy, **STP**, will participate in the **2024 Taiwan Healthcare+ Expo**, seeking Taiwanese partners to create new opportunities in Thailand's physical therapy market.

With the rapid growth of healthcare demand in Indonesia, medical OEM/ODM is becoming a key driver of the country's healthcare industry development. Against this backdrop, PT. Trisa Likuid Farma from Indonesia is participating in Taiwan's Healthcare Technology Expo to establish collaborations with Taiwan's advanced medical technology companies and explore innovative solutions for medical devices and home healthcare products.

Saudi Arabia holds a central position in the Middle Eastern healthcare market, with smart healthcare and digital health becoming pivotal pillars in its medical transformation. The market is growing at an annual rate of 10%. This year, Tamer Health Care, a century-old healthcare group from Saudi Arabia, is participating in the 2024 Taiwan Healthcare Expo, focusing on Taiwan's cutting-edge technologies in smart hospital management systems, telemedicine platforms, and AI medical solutions.

The Philippine government’s active promotion of universal healthcare has significantly improved the country’s medical infrastructure and service quality, directly driving demand in the medical device market. **SERVE DIAGNOSTICA INC**, a renowned IVD distributor in the Philippines, will participate in the Taiwan Healthcare+ Expo this December at the Taipei Nangang Exhibition Center, seeking partnerships and expanding its international business opportunities.

According to market forecasts, the global CDMO market is projected to reach $143.7 billion by 2024 and surpass $247.9 billion by 2029, with a compound annual growth rate (CAGR) of 11.52%. **Nippon Shokubai Co., Ltd.**, a leading global player in the chemical industry, will participate in the 2024 Taiwan Healthcare+ Expo to seek partnerships in Taiwan and explore potential opportunities in the biotech and pharmaceutical sectors.

As the largest stem cell bank company in Southeast Asia, CRYOCORD has established designated partnerships with several hospitals in Malaysia. This year, CRYOCORD will visit the Taiwan Healthcare Technology Expo, aiming to strengthen technological collaboration with Taiwan and introduce stem cell products to the Malaysian market.

Careyn, the largest elderly care provider in the Netherlands, has recently shown a strong interest in the Asian market, particularly in seeking partnerships in Taiwan for the digitalization of home care and preventive healthcare. During its participation in the 2024 Taiwan Healthcare Technology Expo, Careyn aims to identify user-friendly digital care systems and preventive health products suited for elderly home care, with the goal of enhancing the quality of home healthcare services in the Netherlands.

With the surge in chronic disease cases and the ongoing strain of the pandemic on healthcare resources, South Africa's demand for medical equipment is rapidly increasing. During the COVID-19 pandemic, this need became especially pronounced. South Africa’s leading medical equipment distributor, Thogwa, is visiting Taiwan to seek new partnerships to address the growing demand in the South African market.

With Thailand's push to become a "World Medical Tourism Hub" and growing healthcare needs from an aging population, demand for surgical equipment is surging. Sappaya Siam, a leading Thai distributor with partnerships across Thailand and Myanmar, is visiting Taiwan for the Healthcare Expo, seeking collaborations with Taiwanese companies to expand Thailand's medical equipment market and capture new opportunities.

The prevalence of chronic diseases in Indonesia has led to a growing demand for in vitro diagnostics, driving rapid growth in the country's diagnostic laboratory market. It is expected to maintain an annual growth rate of 7.13% through 2029.

JDA Marketing, Inc. from the Philippines, with strong expertise in medical distribution, will attend the Taiwan Healthcare Expo to seek partners in digital healthcare and medical consumables, creating a bridge for Taiwanese companies into the Philippine market.

Emitac Healthcare Solutions is actively engaging in digital transformation, seeking international partnerships to drive innovations like smart hospitals and AI-assisted diagnostics, bringing new momentum to healthcare services in the Middle East and North Africa (MENA) region.

Malaysia’s biotech market is rapidly advancing, positioning itself at the forefront of cell therapy and exosome technology within ASEAN. Malaysian biotech company ALLCELL (M) SDN BHD will be seeking business opportunities at the Taiwan Healthcare+ Expo, focusing on partnerships in biopharmaceuticals, cell therapy, and exosome therapy, offering highly promising collaboration prospects for Taiwanese companies.

South Africa's push to expand its healthcare industry over the next 3 years has opened doors for potential collaborations with Taiwanese smart healthcare companies. As the African Continental Free Trade Area (AfCFTA) advances, Africa's healthcare technology market has captured the interest of global investors, positioning South Africa as a critical player in the region. Stiegelmeyer Africa, the largest hospital equipment distributor in South Africa, aims to leverage Taiwan's expertise in smart healthcare technologies to elevate the quality of care in the local market.

Sigmed, a leading name in medical and veterinary equipment from Poland, is setting its sights on Taiwan as it explores new opportunities in the medical and veterinary sectors. With the steady rise in pet ownership in Poland, the demand for quality veterinary products is growing, but local resources are struggling to keep up. Sigmed sees Taiwan as a potential partner in addressing this gap and aims to establish new collaborations during the Taiwan Healthcare+ Expo this December.

The demand for healthcare technologies and products in the Middle Eastern countries has surged, driven by population growth, medical tourism, and government healthcare policies. As Qatar’s leading medical equipment supplier, Aamal Company is visiting Taiwan to seek innovative technology partners, aiming to introduce smart healthcare technologies to Qatar and address local medical resource shortages.

According to Japan's Ministry of Internal Affairs and Communications, the population aged 65 and over in Japan has reached 36.25 million, accounting for 29.3% of the total population. This marks a historic high as the country continues to face rapid aging.
With the development of an aging society, Japan’s demand for orthopedic medical devices has significantly increased, particularly in areas such as artificial joints and bone filling materials.
HOYA, one of Japan's top 10 medical device manufacturers, sees potential in Taiwan's Asian market. The company is actively seeking partnerships in orthopedic medical devices through the Taiwan Healthcare+ Expo in December, aiming to meet market needs through Taiwan-Japan collaboration.

As the healthcare market in the Middle East in continuously expanding, the United Arab Emirates (UAE) has emerged as a core market due to high demand and growth potential of healthcare. Al Khayyat Investments (AKI), the UAE’s third-largest healthcare distribution, will be visiting Taiwan in December to participate in the Healthcare+ Expo, seeking collaboration opportunities to introduce Taiwan’s innovative healthcare technologies to the Middle East market.

Taiwanese hospitals have embraced AI to address urgent medical needs such as heart attacks, strokes, and respiratory distress. Advanced AI systems enable medical teams to intervene swiftly, significantly improving patient outcomes and survival rates. In the realm of intensive care medicine, where timely interventions are paramount, AI stands as a beacon of hope. As conditions like stroke, sepsis, and critical ICU cases demand swift action, AI-driven solutions offer early warnings, empowering caregivers to make informed decisions and enhance patient outcomes.